Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
Co-Diagnostics Inc (NASDAQ: CODX) closed the day trading at $0.45 down -6.67% from the previous closing price of $0.48. In other words, the price has decreased by -$6.67 from its previous closing price. On the day, 0.52 million shares were traded. CODX stock price reached its highest trading level at $0.56 during the session, while it also had its lowest trading level at $0.45.
Ratios:
For a better understanding of CODX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.70 and its Current Ratio is at 6.92. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.02.
On December 29, 2021, Sidoti started tracking the stock assigning a Buy rating and target price of $14.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CODX now has a Market Capitalization of 14432269 and an Enterprise Value of -20861108. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.45 while its Price-to-Book (P/B) ratio in mrq is 0.23. Its current Enterprise Value per Revenue stands at -2.849 whereas that against EBITDA is 0.54.
Stock Price History:
The Beta on a monthly basis for CODX is 1.04, which has changed by -0.58909094 over the last 52 weeks, in comparison to a change of 0.09589827 over the same period for the S&P500. Over the past 52 weeks, CODX has reached a high of $2.23, while it has fallen to a 52-week low of $0.45. The 50-Day Moving Average of the stock is -33.51%, while the 200-Day Moving Average is calculated to be -57.42%.
Shares Statistics:
Over the past 3-months, CODX traded about 214.01K shares per day on average, while over the past 10 days, CODX traded about 180240 shares per day. A total of 31.93M shares are outstanding, with a floating share count of 29.46M. Insiders hold about 7.73% of the company’s shares, while institutions hold 17.92% stake in the company. Shares short for CODX as of 1740700800 were 193713 with a Short Ratio of 0.91, compared to 1738281600 on 250355. Therefore, it implies a Short% of Shares Outstanding of 193713 and a Short% of Float of 0.64.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The dynamic stock of Co-Diagnostics Inc (CODX) is currently being evaluated by a team of 1.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.34, with high estimates of -$0.34 and low estimates of -$0.34.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is -$1.17, with 1 analysts recommending between -$1.17 and -$1.17.
Revenue Estimates
1 analysts predict $375k in revenue for the current quarter. It ranges from a high estimate of $375k to a low estimate of $375k. As of the current estimate, Co-Diagnostics Inc’s year-ago sales were $3.56MFor the next quarter, 1 analysts are estimating revenue of $400k. There is a high estimate of $400k for the next quarter, whereas the lowest estimate is $400k.
A total of 1 analysts have provided revenue estimates for CODX’s current fiscal year. The highest revenue estimate was $4.14M, while the lowest revenue estimate was $4.14M, resulting in an average revenue estimate of $4.14M. In the same quarter a year ago, actual revenue was $6.81MBased on 1 analysts’ estimates, the company’s revenue will be $1.5M in the next fiscal year. The high estimate is $1.5M and the low estimate is $1.5M.
